{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T13:02:36Z","timestamp":1777726956169,"version":"3.51.4"},"reference-count":9,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Int Med Res"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:p>Over the past two decades, promising advancements have emerged in the field of psoriasis management. Most notably, highly effective targeted biologic therapies that offered significant breakthroughs in the management of psoriasis have been developed. One of the most challenging components of marketing and prescribing these biologic therapies has been in classifying them as immunomodulators or immunosuppressants. The purpose of this narrative review was to discuss the features that distinguish immunomodulators from immunosuppressants to successfully categorize the biologic therapies used for psoriasis management and subsequently enhance patient and physician understanding of the risks associated with the use of these drugs.<\/jats:p>","DOI":"10.1177\/03000605231175547","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T07:36:05Z","timestamp":1686641765000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":7,"title":["Viewpoint about biologic agents for psoriasis: are they immunosuppressants or immunomodulators?"],"prefix":"10.1177","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6617-6621","authenticated-orcid":false,"given":"Dea","family":"Metko","sequence":"first","affiliation":[{"name":"Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0404-0870","authenticated-orcid":false,"given":"Tiago","family":"Torres","sequence":"additional","affiliation":[{"name":"Instituto de Ci\u00eancias Biom\u00e9dicas Abel Salazar, University of Porto, Porto, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2624-2724","authenticated-orcid":false,"given":"Ronald","family":"Vender","sequence":"additional","affiliation":[{"name":"Dermatrials Research Inc., and Venderm Consulting, Hamilton, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2023,6,13]]},"reference":[{"key":"bibr1-03000605231175547","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4006"},{"key":"bibr2-03000605231175547","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800013"},{"key":"bibr3-03000605231175547","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218019"},{"key":"bibr4-03000605231175547","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2010.04.002"},{"key":"bibr5-03000605231175547","first-page":"1","volume-title":"Immunosuppressive and Immunomodulatory Drugs","author":"Kurtzman D","year":"2019","edition":"9"},{"key":"bibr6-03000605231175547","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2004.01.091"},{"key":"bibr7-03000605231175547","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14030654"},{"key":"bibr8-03000605231175547","doi-asserted-by":"publisher","DOI":"10.2174\/1574886310666151014115532"},{"key":"bibr9-03000605231175547","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20081463"}],"container-title":["Journal of International Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03000605231175547","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/03000605231175547","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03000605231175547","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:48:14Z","timestamp":1777459694000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/03000605231175547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":9,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.1177\/03000605231175547"],"URL":"https:\/\/doi.org\/10.1177\/03000605231175547","relation":{},"ISSN":["0300-0605","1473-2300"],"issn-type":[{"value":"0300-0605","type":"print"},{"value":"1473-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6]]},"article-number":"03000605231175547"}}